Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML) is a type of cancer that starts in the blood-forming cells of the bone marrow and leads to the overproduction of myeloid cells, which can crowd out normal blood cells.
Chronic Myeloid Leukemia: TERN-701 Treatment
We are evaluating a new treatment called TERN-701 for individuals with chronic myeloid leukemia. The study aims to assess its safety and how well it works compared to existing options.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut Bergonie
Hematology Department
Bordeaux, France
Institut Paoli-Calmettes
Hematology
Marseille, France
Centre Leon Berard
Medical Oncology
Meyzieu, France
Sponsor: Terns Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.